About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

GliomaAI-GBM: MRI-Based Detection of IDH Wildtype Glioblastoma

NCT07673692·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Deep Learning Institute of Radiological Sciences

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Adult (\>=18 years of age)
Having pre op MRI scan
Having biopsy / surgery
Having post biopsy/ surgery histology diagnosis and genetic analysis.

You may not be if

MRI scan significantly degraded by motion or other artefact
Incomplete genetic analysis
Prior treatment (e.g., radiotherapy or chemotherapy) before baseline MRI

The record

StatusCompleted

PhaseNo phase

Taking part1,372

StartedMar 2017

UpdatedJun 29, 2026

Conditions

Glioma Glioma (Diagnosis)Glioblastom WHO Grade 4 IDH Wildtype Glioblastoma

Where1

Deep Learning Institute of Radiological Sciences
Mumbai, India

Clareo Health | GliomaAI-GBM: MRI-Based Detection of IDH Wildtype Glioblastoma